The novel synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) has been recently identi®ed to be a potent inducer of apoptosis in human non-small cell lung carcinoma (NSCLC) cells through a nuclear retinoic acid receptor independent mechanism. To approach the mechanism by which CD437 induces apoptosis in NSCLC cells, we investigated the involvement of c-Myc in CD437-induced apoptosis. CD437 (1 mM) up-regulated the expression of c-Myc and of its downstream target genes ornithine decarboxylase (ODC) and cdc25A in all three NSCLC cell lines (i.e., H460, SK-MES-1 and H1792) used. These eects were correlated with cellular susceptibilities to induction of apoptosis by CD437. Furthermore, CD437-induced apoptosis could be blocked by the ODC inhibitor di¯uoromethylornithine, the caspase inhibitors Z-VAD FMK and Z-DEVD FMK, and cMyc antisense oligodeoxynucleotide, respectively. These data indicate that c-Myc gene plays an important role in mediating CD437-induced apoptosis in human NSCLC cells.
Introduction
Retinoids, a group of natural and synthetic vitamin A analogs, play an important role in regulation of cell growth, apoptosis, dierentiation, development and carcinogenesis (Gudas et al., 1994; Lotan, 1995) . They are promising agents for the prevention and treatment of several human malignancies including lung cancer (Smith et al., 1992; Hong and Itri, 1994; Benner et al., 1995) . Retinoids can suppress the growth and squamous dierentiation of bronchial epithelial cells (Jetten et al., 1992) . However, it appears that lung carcinogenesis is associated with acquisition of refractoriness to retinoids as most non-small cell lung carcinoma (NSCLC) cell lines are resistant to all-trans-retinoic acid (ATRA) and many synthetic retinoids in vitro (Geradts et al., 1993; Kim et al., 1995; Sun et al., 1997a) .
Retinoid signaling is mediated by two types of nuclear receptors, retinoic acid receptors (RARs, a, b, and g) and retinoid X receptors (RXRs, a, b, and g), which belong to the steroid hormone receptor gene superfamily. The retionoid receptors are liganddependent transcription factors that regulate transcription by forming RXR ± RAR heterodimers that bind to speci®c DNA sequences or interact with other transcription factors (Pfahl, 1994; Mangelsdorf and Evans, 1995; Chambon, 1996) . Following the discovery of nuclear retinoid receptors, eorts were directed towards identifying novel retinoids with dierent receptor selectivity pro®les that could bind and transactivate either RARs or RXRs or that were selective for one receptor subtype (e.g., a, b, or g). The availability of new receptor-selective retinoids raised the possibility that some of them may be more eective against lung cancer cells than ATRA.
Recently, the novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) has been identi®ed by us to be the most eective one among 37 synthetic receptor-selective retinoids in inhibiting the growth of a group of NSCLC cell lines (Sun et al., 1997a) . Furthermore, this retinoid has been identi®ed to be a potent inducer of apoptosis in human lung cancer (Sun et al., 1997b; Adachi et al., 1998; Li et al., 1998) , breast cancer (Shao et al., 1995) , cervical cancer (Oridate et al., 1997) , melanoma (Schadendorf et al., 1996) and leukemia (Hsu et al., 1997) cells. CD437 can selectively bind and activate RARg receptor (Bernard et al., 1992) . However, the apoptosis induced by CD437 has been found to be independent of nuclear retinoid receptor pathway or of AP-1 transrepression (Sun et al., 1997b; Shao et al., 1995; Hsu et al., 1997) . Thus, another mechanism should account for CD437's eects.
Apoptosis is an active form of cell death that plays an essential role in the maintenance of homeostasis in multicellular organisms through elimination of unwanted cells. This kind of active cellular suicide is a complex and tightly regulated process, which is genetically controlled by a number of distinct genes, including oncogenes such as c-Myc, c-Jun and c-Fos, and tumor suppressor gene p53 as well as its regulated genes such as bcl-2, bax, and p21 (Stewart, 1994; Martin and Green, 1995a; Jehn and Osborne, 1997) . The apoptosis induced by CD437 in breast cancer cells was reported to be independent of p53 but to be related to p21 induction (Shao et al., 1995; Li et al., 1996) , upregulation of bax and downregulation of bcl-2 (Shao et al., 1995) . However, we found that both p53-dependent and -independent pathways are involved in mediating CD437-induced apoptosis in NSCLC cells (Sun et al., 1999) . Further, we (Oridate et al., 1997) and others (Adachi et al., 1998) found that CD437-induced apoptosis may not involve bcl-2 family genes such as bcl-2, bcl-XL and bax. More recently, CD437-induced apoptosis has been identi®ed to require caspase activation in various cancer cells (Piedra®ta and Pfahl, 1997) , including human NSCLC cells (Sun et al., 1999) . In addition, CD437-induced apoptosis was also reported to be related to AP-1 activation in human melanoma cells (Schadendorf et al., 1996) and lung cancer cells (Li et al., 1998) .
c-Myc oncoprotein is a transcription activating factor implicated in the regulation of cell proliferation, dierentiation and transformation (Marcu et al., 1992; Desbarats et al., 1996) . More recently, however, c-Myc has also been found to induce apoptotic cell death under certain circumstances such as deprivation of survival factors, viral infection, T-cell receptor activation, tumor necrosis factor, and chemotherapeutic agents (Desbarats et al., 1996; Packham and Cleveland, 1995) . Furthermore, transcriptional activation of target genes such as ornithine decarboxylase (ODC), p53, and cdc25A contributes to c-Myc-mediated apoptosis (Hermeking and Eick, 1994; Cleveland, 1994, 1995; Galaktionov et al., 1996) .
In the present study, we investigated the eects of CD437 on the expression of c-Myc gene and its target genes ODC and cdc25A in human NSCLC cells and the possible role of c-Myc in CD437-induced apoptosis. CD437 up-regulates c-Myc expression and its downstream target genes ODC and cdc25A in all three NSCLC cell lines tested. Furthermore, this eect was correlated with cellular susceptibilities to induction of apoptosis by CD437. CD437-induced apoptosis could be blocked by the ODC inhibitor difluoromethylornithine (DFMO), the caspase inhibitors Z-VAD FMK and Z-DEVD FMK, and c-Myc antisense oligodeoxynucleotides, respectively. These results strongly suggest that c-Myc gene plays an important role in mediating CD437-induced apoptosis in human NSCLC cells.
Results

NSCLC cell lines exhibit dierential sensitivity to induction of apoptosis by CD437
We used three NSCLC cell lines H1792 (adenocarcinoma), SK-MES-1 (squamous carcinoma), and H460 (large cell carcinoma), that have dierent histological origin (Mitsudomi et al., 1992) in this study. First, we compared the sensitivity of these cell lines to induction of apoptosis by CD437. Figure 1 demonstrates that CD437 induced time-and dose-dependent apoptosis evidenced by decreased cell survival ( Figure 1a ) and increased DNA breaks with 3'-OH ends measured by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL)-¯ow cytometry assay (Figure 1b) in the three NSCLC cell lines. However, these three cell lines clearly showed dierential sensitivity to CD437 treatment. H460 was the most sensitive one and H1792 was the least sensitive one to induction of apoptosis by CD437. SK-MES-1 cells exhibited an intermediate response level. It is worth mentioning that longer treatment with CD437 has led to increased apoptosis in the less sensitive cell lines ( Figure 1a ).
Modulation of c-Myc gene expression by CD437
CD437 (1 mM) upregulated the expression of c-Myc mRNA in the three NSCLC cell lines in a timedependent fashion ( Figure 2 ). In H460 cells, c-Myc mRNA was induced by 15 min and reached a peak at 2 h, however, after 3 h, c-Myc mRNA level dropped below the control level and was further decreased at 24 h (Figure 2a and b) . A similar regulation pattern of c-Myc by CD437 was also observed in SK-MES-1 cells, in which c-Myc mRNA was quickly upregulated to the highest level within 6 h, and then dropped below control level at 24 h ( Figure 2c ). In H1792 cells, cMyc mRNA was slowly upregulated by CD437, beginning at 3 h and reaching peak level at 12 h ( Figure 2d ). This high level of c-Myc mRNA was sustained even at 24 h. In both SK-MES-1 ( Figure 2c ) and H1792 ( Figure 2d ) cells, there was a decrease in cMyc mRNA level after 1.5 h of CD437 treatment that preceded the increase in c-Myc observed at 3 h. It is unclear whether the initial decline or the subsequent increase of c-Myc mRNA is triggering apoptosis in CD437-treated cells. We also found an increase of cMyc expression by CD437 at the protein level in these three cell lines (Figure 2e ). There appears to be a Figure 1 Dierential sensitivities of human NSCLC cell lines to induction of apoptosis by CD437. (a) Time-and concentrationdependent eects of CD437 on cell survival evaluated by determination of relative cell number using SRB assay as described in Materials and methods. Each point is the mean+s.d. of six replicate determinations. (b) Concentration-dependent induction of apoptosis after the cells were exposed to CD437 for 24 h evaluated by TUNEL-¯ow cytometry assay as described in Materials and methods correlation between cell sensitivity to apoptosis induction and an early c-Myc upregulation followed by a subsequent decline in expression.
Modulation of ODC gene expression by CD437
ODC is one of c-Myc's target genes and plays an important role in mediating c-Myc-induced apoptosis Cleveland, 1994, 1995) . Therefore, we determined whether ODC gene expression was modulated by CD437 following the c-Myc upregulation. As shown in Figure 2 , ODC mRNA was induced by CD437 in the three NSCLC cell lines in a pattern similar to the patterns of c-Myc modulation although there is not always a tight association between a c-Myc and ODC expression. There was a tight temporal association between c-Myc and ODC mRNA modulation. Because the peak of ODC mRNA induction by CD437 was observed later than that of c-Myc mRNA induction, c-Myc mRNA induction may be the cause of ODC mRNA induction. Like c-Myc, ODC induction also appears to be associated with cell sensitivity to apoptosis induction.
Modulation of cdc25A gene expression by CD437
cdc25A is another c-Myc target gene that is important for mediating c-Myc-induced apoptosis (Galaktionov et al., 1996) . CD437 upregulated cdc25A protein level in the three NSCLC cell lines (Figure 3) . The induction was associated with cell responsiveness to CD437-induced apoptosis. cdc25A protein was induced early (1.5 h) in H460 cells, which are the most sensitive to CD437 treatment, and later (12 h) in H1792 cells, which are the least sensitive to CD437 (Figure 3 ). The level of cdc25A increased in untreated H460 and SK-MES-1 cells with time albeit to levels that were higher than the corresponding CD437-treated cells.
Eect of ODC inhibitor DFMO on CD437-induced apoptosis
To determine whether ODC was important for CD437-induced apoptosis, we assessed the eects of the ODC inhibitor DFMO on the response of the cells to CD437 in the NSCLC cell. As shown in Figure 4 , DFMO at 5 and 10 mM suppressed CD437-induced apoptosis in SK-MES-1 and H460 cells, indicating that ODC participates, at least partially, in CD437-induced apoptosis in these two cell lines. However, DFMO failed to rescue H1792 cells from CD437-induced apoptosis, suggesting a less important role if any for ODC in apoptosis induction in H1792 cells.
Eects of caspase inhibitors on CD437-induced apoptosis
Recently, the important role of caspases, especially caspase-3 or CPP32, in c-Myc-mediated apoptosis has been highlighted (Kagaya et al., 1997; Kangas et al., 1998) . CD437 induced CPP32-like caspase activation (Figure 5a ), which was accompanied by increased DNA fragmentation (Figure 5b ). However, CD437-induced CPP32-like caspase activation and apoptosis were almost completely blocked in the presence of the caspase inhibitors Z-VAD-FMK and Z-DEVD-FMK ( Figure 5 ) in SK-MES-1 cells. Therefore, this result indicates that CPP32 or CPP32-like caspase activation is necessary event for CD437-induced apoptosis.
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Eects of antisense c-Myc oligodeoxynucleotide on CD437-induced apoptosis
If c-Myc plays an important role in mediating CD437-induced apoptosis, CD437-induced apoptosis is expected to be reversed by addition of antisense c-Myc oligodeoxynucleotide (AS-myc). Indeed, CD437-induced apoptosis in H1792 cells was completely reversed by AS-myc (Figure 6a ). The small decrease in CD437-induced DNA fragmentation by sense (S-myc) or nonsense (NS-myc) oligodeoxynucleotides were not statistically significant based on results of three independent experiments. In order to con®rm that AS-myc works through suppression of c-Myc protein expression, we further performed Western blot analysis for c-Myc expression. As shown in Figure  6b , increased c-Myc protein expression by CD437 was only suppressed by AS-myc but not by S-myc or NS-myc. Therefore, these results indicate that cMyc is involved in CD437-induced apoptosis in these cells. 
Discussion
In this study, we found that CD437 upregulated cMyc mRNA expression followed by induction of apoptosis in NSCLC cells. Therefore, we investigated the role of c-Myc in CD437-induced apoptosis in NSCLC cells. Several lines of evidence indicate that cMyc plays a role in mediating CD437-induced apoptosis in NSCLC cells. First, the kinetics of CD437-induced c-Myc expression correlated with the induction of apoptosis, i.e., the cells in which c-Myc expression was rapidly upregulated were more sensitive to induction of apoptosis by CD437. Second, two c-Myc target genes, ODC and cdc25A, which are major mediators of c-Myc-induced apoptosis (Packham and Cleveland, 1994; Galaktionov et al., 1996) , were also upregulated by CD437 in a similar time course as c-Myc induction. Third, the ODC inhibitor DFMO suppressed CD437-induced apoptosis. Finally, c-Myc antisense oligodeoxynucleotide reversed CD437-induced apoptosis. These data strongly support the idea that CD437 treatment results in upregulation of c-Myc and its target genes, which contribute to CD437-induced apoptotic cell death in human NSCLC cells. To our knowledge, this is the ®rst demonstration that c-Myc mediates CD437-induced apoptosis in human cancer cells.
Speci®c proteases play pivotal roles in the cell death machinery (Patel et al., 1996; Martin and Green, 1995b) . Of the ten known caspases, caspase-3 or CPP32 is one of the strongest candidates for being a mammalian cell death-inducing protease that cleaves PARP and other vital proteins (Patel et al., 1996; Martin and Green, 1995b) . Recently, it has been suggested that CPP32-like caspase plays a critical role in c-Myc-mediated apoptosis (Kagaya et al., 1997; Kangas et al., 1998) . Our previous study (Sun et al, 1999) showed that the caspase inhibitors Z-DEVD FMK and Z-VAD FMK could block not only CD437-induced CPP32-like caspase activation but also CD437-induced apoptosis in H1792 and H460 cells. In the present study, we extended this ®nding by showing that the Z-DEVD FMK and Z-VAD FMK could also block CD437-induced CPP32-like caspase activation and CD437-induced apoptosis in SK-MES-1 cells. Clearly, these results are also compatible with the involvement of c-Myc in mediating CD437-induced apoptosis in NSCLC cells.
The ODC gene is the best example of a direct transcriptional target of c-Myc that contributes to cMyc's biological activities in cells (Packham and Cleveland, 1995) . In myeloid cells, enforced expression of ODC enzyme, like c-Myc, is sucient to induce apoptosis (Packham and Cleveland, 1994) . Importantly, DFMO, a speci®c irreversible inhibitor of ODC enzyme activity, delays c-Myc-induced Figure 3 Induction of cdc25A expression by CD437 in NSCLC cells. Cells were treated with 1 mM CD437 for the indicated times on the second day after seeding. Whole cell lysates was prepared, and 50 mg protein per lane were loaded for Western blot analysis as described in Materials and methods. N.S., non-speci®c. Cleveland, 1994) , indicating that ODC-independent pathways also exist in these cells. In our study, ODC mRNA was induced by CD437 in the three NSCLC cell lines in parallel with the induction of c-Myc expression. However, the level of the ODC induction in general was not as high as that of the c-Myc induction. Moreover, DFMO only partially blocked CD437-induced apoptosis in two of the NSCLC cell lines (SK-MES and H460). Therefore, we conclude that ODC may contribute to CD437-induced apoptosis in SK-MES and H460 cells but other eector genes of c-Myc may also play some role. In H1792 cells, ODC may play a less important role if any in CD437-induced apoptosis.
Cdc25A is a phosphatase that activates cyclindependent kinases essential for a G1-to-S transition (Draetta and Eckstein, 1997) . Recently, cdc25A has been identi®ed to be another c-Myc target gene that is important for mediating c-Myc-induced apoptosis (Galaktionov et al., 1996) . In ®broblasts, overexpression of cdc25A augments apoptosis induced by serum deprivation and suppression of cdc25A expression blocks apoptosis induced by enforced cMyc expression (Galaktionov et al., 1996) . In our study, CD437 upregulated the expression of cdc25A in all three NSCLC cell lines, and this eect was associated with the sensitivity of the cells to induction of apoptosis by CD437, suggesting that cdc25A also contributes to CD437-induced apoptosis in NSCLC cells. Cdc25A levels increased with time even in untreated H460 and SK-MES-1 cells, without inducing apoptosis, suggesting that cdc25A may be important but not sucient for induction of apoptosis in these cells.
Besides ODC and cdc25A, p53 is another c-Myc target gene, which mediates c-Myc-induced apoptosis in some cell types (Hermeking and Eick, 1994; Wagner et al., 1994) . However, c-Myc-induced apoptosis by a p53-independent mechanism was also reported (Sakamuro et al., 1995; Hsu et al., 1995) . In our study, SK-MES-1 and H1792 cells, which contain mutant p53 (Mitsudomi et al., 1992; Ramet et al., 1995) were killed by CD437, therefore, CD437-induced apoptosis in these two cell lines must be p53-independent. In contrast, in H460 that have wild-type p53 (Mitsudomi et al., 1992) , p53 may be involved in CD437-induced apoptosis. The relationship between c-Myc and p53 in CD437-induced apoptosis in H460 cells is being explored by ongoing study. 
Materials and methods
Reagents
CD437 was synthesized by CIRD/Galderma (Sophia Antipolis, France). It was dissolved in dimethylsulfoxide (DMSO) at a concentration of 10 mM and stored in the dark at 7808C under N 2 atmosphere. Stock solutions were diluted to the appropriate ®nal concentrations with growth medium just prior to use. DFMO was a gift from Dr Ajit Verma (University of Wisconsin, Madison, WI, USA). The caspase inhibitors N-benzyloxycarbonyl-Val-Ala-Asp-¯uoromethyl-ketone (Z-VAD FMK) and N-benzyloxycarbonyl-Asp-GluVal-Asp-¯uoromethyl-ketone (Z-DEVD FMK) were purchased from Enzyme System Products (Livermore, CA, USA). The¯uorogenic substrate N-acetyl-Asp-Glu-Val-Asp-AFC (Ac-DEVD-AFC) for CPP32-like caspase activity assay was obtained from Biomol (Plymouth Meeting, PA, USA).
Cell culture and cell survival assay
Human NSCLC cell lines were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA) (SK-MES-1) or Dr Adi Gazdar (University of Texas Southwestern Medical Center, Dallas, TX, USA) (H1792 and H460) and were grown in monolyer culture in a 1 : 1 (v/v) mixture of Dubecco's modi®ed Eagle's medium and Ham's F12 medium containing 5% FCS and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin) at 378C. The cell survival assay was performed using the sulforhodamine B (SRB) assay as described previously (Sun et al., 1997a) .
Apoptosis assay
Apoptosis was evaluated by the TUNEL-¯ow cytometry assay using APO-DIRECT TM kit (Phoenix Flow Systems, Inc., San Diego, CA, USA) and the ELISA assay using Cell Death Detection plus kit (Boehringer-Mannheim, Indianapolis, IN, USA) following the manufacturer's protocols.
RNA puri®cation and Northern blotting
Total cellular RNA puri®cation and Northern blotting were performed as described previously (Sun et al., 1997a) . Plasmid pMK934 containing mouse ODC cDNA was obtained from ATCC. pSVc-Myc-1 plasmid containing mouse c-Myc cDNA were obtained from Dr Paul Chiao (UT MD Anderson Cancer Center, Houston, TX, USA). The cDNA for glyceraldehyde phosphate dehydrogenase (GADPH) was used to control for RNA loading. mRNA quantitation was done by using the NIHimage 1.61 software.
Protein extraction and Western blotting
Cells were washed in PBS and lysed in a buer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% sodium dodecylsulfate (SDS), 1% Nonidet P-40, 1 mM phenylmethylsulfonyl¯uoride, 5 mg/ml aprotinin and 5 mg/ml leupetin. After incubation on ice for 15 min and centrifugation at 12 000 r.p.m. for 10 min, the supernatants were collected and the protein concentration was determined with the Protein Assay Kit (Bio-Rad, Hercules, CA, USA). The whole cell lysates (50 or 20 mg) were resolved on 10% SDS-denatured gel and transferred to Protran TM nitrocellulose membranes (Schleicher & Schuell, Keene, NH USA). The blots were probed with rabbit polyclonal anti-cdc25A antibody 144 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) or mouse monoclonal anti-c-Myc antibody (9E10) (Santa Cruz Biotechnology, Inc.) and developed with the enhanced chemiluminescence (ECL) system (Amersham, Arlington Heights, IL, USA).
Measurement of CPP32-like caspase activity
CPP32-like caspase activity was measured as described previously (Kagaya et al., 1997) . Brie¯y, cells were collected and lysed for 20 min on ice in lysis buer containing 10 mM HEPES-KOH (pH 7.4), 2 mM EDTA, 0.1% 3-[(3-cholamidopropyl) dimethyl-ammonio ] -1 -propanesulfonats (CHAPS), 1 mM PMSF, and 5 mM DTT. After centrifugation, the supernatants were collected as lysates. For measurement of caspase activity, 100 mg lysate proteins in 50 ml of lysis buer were mixed with 50 ml of 26reaction buer containing 40 mM HEPES-KOH (pH 7.4), 20% glycerol, 1 mM PMSF, and 4 mM DTT with 50 mM¯uorogenic substrate Ac-DEVD-AFC in 96-well (¯at bottom) cell culture plate and incubated at 378C for 1 h. The¯uorescence was measured at 400 nm excitation and 500 nm emission wavelengths in a CytoFluor 2350 Fluorescence Measurement System (Millipore, Bedford, MA, USA). The¯uorescent intensities were used to represent relative activity of CPP32-like caspase.
Phosphorothioate oligodeoxynucleotides
A 15-mer antisense c-Myc 5'-CACGTTGAGGGGCAT-3' complementary to the translation initiation region of c-Myc mRNA was used. As control, a sense c-Myc 5'-ATGCCCCT-CAACGTG-3', and a nonsense sequence 5'-AGTGGCGGA-GACTCT-3' were used (Klefstrom et al., 1994) . These oligodeoxynucleotides were synthesized by Gibco Life Technologies, Inc. (Gaithersburg, MD, USA).
